Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:12:21.345Z.
Calculation as of: 2026-10-06T16:12:21.345Z.
Quote observation: 2026-10-06T16:09:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9eab42942c27d7457dfc33c45bb783e1a271ca5ab59202131f9efdd6250b8ad0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Healthcare Triangle, Inc.
Market Cap
$8.48M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.48M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.34M | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.15M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.10M | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $7.95M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.23M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.25M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.33M | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
